Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25259657 | 0.86 | — | — | |
| SCHEMBL6879181 | 0.86 | VCP (0.31) | — | |
| SCHEMBL809345 | 0.84 | VCP (0.33) | — | |
| SCHEMBL14876922 | 0.81 | — | — | |
| SCHEMBL419449 | 0.81 | VCP (0.38) | — | |
| SCHEMBL2238115 | 0.79 | — | — | |
| SCHEMBL1808857 | 0.78 | VCP (0.36) | — | |
| SCHEMBL27632776 | 0.78 | ERN1 (0.36) | ERN1 | |
| SCHEMBL25863028 | 0.78 | — | — | |
| SCHEMBL22042201 | 0.77 | MEN1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312348-B2 | RET inhibitors, pharmaceutical compositions and uses thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2025-05-27 | — | — | US | disclosed |
| CN-113906577-B | Organic light emitting device | 株式会社LG化学 | 2025-02-21 | — | — | CN | disclosed |
| EP-4181224-B1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2025-01-01 | — | — | EP | disclosed |
| CN-111285874-B | RET inhibitor, pharmaceutical composition thereof and application thereof | 广东东阳光药业股份有限公司 | 2024-08-09 | — | — | CN | disclosed |
| US-11997921-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2024-05-28 | — | — | US | disclosed |
| CN-114171691-B | Organic light emitting device | 株式会社LG化学 | 2024-03-26 | — | — | CN | disclosed |
| CN-113795477-B | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-12-12 | — | — | CN | disclosed |
| CN-117164446-A | Photocatalytic oxidative degradation method for polymer containing styrene structural unit | 大连理工大学 | 2023-12-05 | — | — | CN | disclosed |
| US-20230309369-A1 | Organic Light-Emitting Device | LG CHEM, LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| US-20230309369-A1 | Organic Light-Emitting Device | LG CHEM, LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| EP-3524646-A1 | IONIC COMPOUND, COATING COMPOSITION COMPRISING SAME, AND ORGANIC LIGHT-EMITTING DIODE | LG Chem, Ltd. (KR) | 2019-08-14 | — | — | EP | disclosed |
| EP-3511382-A1 | ORGANIC LIGHT-EMITTING DIODE | LG Chem, Ltd. (KR) | 2019-07-17 | — | — | EP | disclosed |
| EP-0271240-B1 | Fluorobenzyl esters | ZENECA LTD (GB) | 1994-01-19 | — | — | EP | disclosed |
| US-5132469-A | Insecticides, Miticides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-07-21 | — | — | US | disclosed |
| US-5017606-A | Insecticides, miticides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-05-21 | — | — | US | disclosed |
| EP-0196156-B1 | FLUOROBENZYL ESTERS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-02-07 | — | — | EP | disclosed |
| US-4762835-A | INSECTICIDES, MITICIDES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-08-09 | — | — | US | disclosed |
| EP-0271240-A2 | Fluorobenzyl esters | ZENECA LIMITED (GB) | 1988-06-15 | — | — | EP | disclosed |
| EP-0227415-A2 | Pyrimidine derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-07-01 | — | — | EP | disclosed |
| EP-0196156-A1 | Fluorobenzyl esters | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12312348-B2 | RET inhibitors, pharmaceutical compositions and uses thereof | RET, SLC10A2, REL | ERN1 3247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.